Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 27, 2019

Primary Completion Date

October 20, 2021

Study Completion Date

November 25, 2021

Conditions
Diabetes Mellitus, Type 2MetagenomeGenetic Predisposition
Interventions
DIAGNOSTIC_TEST

16S rRNA gene sequencing

Taking a stool sample for gut microbiome DNA sequencing

GENETIC

DNA-microarray genotyping

Taking a saliva sample for genotyping

Trial Locations (1)

Unknown

City Clinical Hospital V.P. Demikhova, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Atlas Biomed

INDUSTRY

NCT04113239 - Study of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter